nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilostazol—CYP3A4—bone cancer	0.765	1	CbGaD
Cilostazol—CYP1A2—Lidocaine metabolism—CYP3A4—bone cancer	0.00191	0.0703	CbGpPWpGaD
Cilostazol—CYP3A7—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00144	0.053	CbGpPWpGaD
Cilostazol—CYP3A5—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00104	0.0383	CbGpPWpGaD
Cilostazol—CYP2C19—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000803	0.0296	CbGpPWpGaD
Cilostazol—CYP2D6—Codeine and Morphine Metabolism—CYP3A4—bone cancer	0.000742	0.0274	CbGpPWpGaD
Cilostazol—CYP2D6—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000739	0.0272	CbGpPWpGaD
Cilostazol—CYP1A2—Aflatoxin B1 metabolism—CYP3A4—bone cancer	0.000699	0.0258	CbGpPWpGaD
Cilostazol—CYP3A7—Xenobiotics—CYP3A4—bone cancer	0.000694	0.0256	CbGpPWpGaD
Cilostazol—CYP3A5—Irinotecan Pathway—CYP3A4—bone cancer	0.000667	0.0246	CbGpPWpGaD
Cilostazol—CYP1A2—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000626	0.0231	CbGpPWpGaD
Cilostazol—CYP3A7—Metapathway biotransformation—CYP4V2—bone cancer	0.000619	0.0228	CbGpPWpGaD
Cilostazol—CYP3A5—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.000522	0.0193	CbGpPWpGaD
Cilostazol—CYP3A5—Xenobiotics—CYP3A4—bone cancer	0.000501	0.0185	CbGpPWpGaD
Cilostazol—CYP3A4—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.000483	0.0178	CbGpPWpGaD
Cilostazol—CYP3A5—Tamoxifen metabolism—CYP3A4—bone cancer	0.000482	0.0178	CbGpPWpGaD
Cilostazol—Cardiac failure—Doxorubicin—bone cancer	0.00047	0.00227	CcSEcCtD
Cilostazol—Cerebrovascular accident—Doxorubicin—bone cancer	0.000468	0.00226	CcSEcCtD
Cilostazol—Nervous system disorder—Cisplatin—bone cancer	0.000465	0.00225	CcSEcCtD
Cilostazol—Thrombocytopenia—Cisplatin—bone cancer	0.000464	0.00224	CcSEcCtD
Cilostazol—Blood creatinine increased—Epirubicin—bone cancer	0.000464	0.00224	CcSEcCtD
Cilostazol—Tachycardia—Cisplatin—bone cancer	0.000463	0.00223	CcSEcCtD
Cilostazol—Skin disorder—Cisplatin—bone cancer	0.000461	0.00222	CcSEcCtD
Cilostazol—Gastrointestinal haemorrhage—Doxorubicin—bone cancer	0.000459	0.00221	CcSEcCtD
Cilostazol—Diplopia—Doxorubicin—bone cancer	0.000459	0.00221	CcSEcCtD
Cilostazol—Asthma—Methotrexate—bone cancer	0.000458	0.00221	CcSEcCtD
Cilostazol—Liver function test abnormal—Epirubicin—bone cancer	0.000458	0.00221	CcSEcCtD
Cilostazol—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—bone cancer	0.000454	0.0168	CbGpPWpGaD
Cilostazol—Dry skin—Epirubicin—bone cancer	0.000454	0.00219	CcSEcCtD
Cilostazol—Orthostatic hypotension—Epirubicin—bone cancer	0.000453	0.00219	CcSEcCtD
Cilostazol—Anorexia—Cisplatin—bone cancer	0.000452	0.00218	CcSEcCtD
Cilostazol—CYP3A5—Metapathway biotransformation—CYP4V2—bone cancer	0.000447	0.0165	CbGpPWpGaD
Cilostazol—Hypotension—Cisplatin—bone cancer	0.000443	0.00214	CcSEcCtD
Cilostazol—Face oedema—Doxorubicin—bone cancer	0.000443	0.00214	CcSEcCtD
Cilostazol—Gastritis—Epirubicin—bone cancer	0.000439	0.00212	CcSEcCtD
Cilostazol—Cardiac arrest—Doxorubicin—bone cancer	0.000436	0.0021	CcSEcCtD
Cilostazol—Pancytopenia—Methotrexate—bone cancer	0.000435	0.0021	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000432	0.00209	CcSEcCtD
Cilostazol—Blood creatinine increased—Doxorubicin—bone cancer	0.00043	0.00207	CcSEcCtD
Cilostazol—Asthma—Epirubicin—bone cancer	0.000428	0.00207	CcSEcCtD
Cilostazol—Influenza—Epirubicin—bone cancer	0.000428	0.00207	CcSEcCtD
Cilostazol—CYP2D6—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000426	0.0157	CbGpPWpGaD
Cilostazol—Paraesthesia—Cisplatin—bone cancer	0.000426	0.00206	CcSEcCtD
Cilostazol—Liver function test abnormal—Doxorubicin—bone cancer	0.000423	0.00204	CcSEcCtD
Cilostazol—Dyspnoea—Cisplatin—bone cancer	0.000423	0.00204	CcSEcCtD
Cilostazol—Dry skin—Doxorubicin—bone cancer	0.00042	0.00203	CcSEcCtD
Cilostazol—Orthostatic hypotension—Doxorubicin—bone cancer	0.000419	0.00202	CcSEcCtD
Cilostazol—Angina pectoris—Epirubicin—bone cancer	0.000417	0.00201	CcSEcCtD
Cilostazol—Decreased appetite—Cisplatin—bone cancer	0.000412	0.00199	CcSEcCtD
Cilostazol—Bronchitis—Epirubicin—bone cancer	0.000412	0.00199	CcSEcCtD
Cilostazol—Pneumonia—Methotrexate—bone cancer	0.00041	0.00198	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Cisplatin—bone cancer	0.000409	0.00198	CcSEcCtD
Cilostazol—Pancytopenia—Epirubicin—bone cancer	0.000407	0.00196	CcSEcCtD
Cilostazol—Gastritis—Doxorubicin—bone cancer	0.000406	0.00196	CcSEcCtD
Cilostazol—Pain—Cisplatin—bone cancer	0.000406	0.00196	CcSEcCtD
Cilostazol—Stevens-Johnson syndrome—Methotrexate—bone cancer	0.000405	0.00195	CcSEcCtD
Cilostazol—Conjunctivitis—Methotrexate—bone cancer	0.000397	0.00192	CcSEcCtD
Cilostazol—Influenza—Doxorubicin—bone cancer	0.000396	0.00191	CcSEcCtD
Cilostazol—Asthma—Doxorubicin—bone cancer	0.000396	0.00191	CcSEcCtD
Cilostazol—Pollakiuria—Epirubicin—bone cancer	0.000396	0.00191	CcSEcCtD
Cilostazol—Feeling abnormal—Cisplatin—bone cancer	0.000391	0.00189	CcSEcCtD
Cilostazol—Haematuria—Methotrexate—bone cancer	0.000389	0.00188	CcSEcCtD
Cilostazol—CYP2C19—Xenobiotics—CYP3A4—bone cancer	0.000388	0.0143	CbGpPWpGaD
Cilostazol—Angina pectoris—Doxorubicin—bone cancer	0.000386	0.00186	CcSEcCtD
Cilostazol—Hepatobiliary disease—Methotrexate—bone cancer	0.000386	0.00186	CcSEcCtD
Cilostazol—Epistaxis—Methotrexate—bone cancer	0.000385	0.00186	CcSEcCtD
Cilostazol—Pneumonia—Epirubicin—bone cancer	0.000384	0.00185	CcSEcCtD
Cilostazol—Bronchitis—Doxorubicin—bone cancer	0.000381	0.00184	CcSEcCtD
Cilostazol—Agranulocytosis—Methotrexate—bone cancer	0.000381	0.00184	CcSEcCtD
Cilostazol—Stevens-Johnson syndrome—Epirubicin—bone cancer	0.000379	0.00183	CcSEcCtD
Cilostazol—Pancytopenia—Doxorubicin—bone cancer	0.000376	0.00182	CcSEcCtD
Cilostazol—Body temperature increased—Cisplatin—bone cancer	0.000375	0.00181	CcSEcCtD
Cilostazol—CYP2C19—Tamoxifen metabolism—CYP3A4—bone cancer	0.000373	0.0137	CbGpPWpGaD
Cilostazol—Jaundice—Epirubicin—bone cancer	0.000372	0.0018	CcSEcCtD
Cilostazol—Conjunctivitis—Epirubicin—bone cancer	0.000371	0.00179	CcSEcCtD
Cilostazol—Urinary tract infection—Epirubicin—bone cancer	0.000371	0.00179	CcSEcCtD
Cilostazol—Haemoglobin—Methotrexate—bone cancer	0.000368	0.00178	CcSEcCtD
Cilostazol—Haemorrhage—Methotrexate—bone cancer	0.000366	0.00177	CcSEcCtD
Cilostazol—Pollakiuria—Doxorubicin—bone cancer	0.000366	0.00177	CcSEcCtD
Cilostazol—Haematuria—Epirubicin—bone cancer	0.000364	0.00176	CcSEcCtD
Cilostazol—Pharyngitis—Methotrexate—bone cancer	0.000364	0.00176	CcSEcCtD
Cilostazol—Hepatobiliary disease—Epirubicin—bone cancer	0.000361	0.00174	CcSEcCtD
Cilostazol—CYP1A2—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000361	0.0133	CbGpPWpGaD
Cilostazol—Epistaxis—Epirubicin—bone cancer	0.00036	0.00174	CcSEcCtD
Cilostazol—Sinusitis—Epirubicin—bone cancer	0.000358	0.00173	CcSEcCtD
Cilostazol—CYP2D6—Xenobiotics—CYP3A4—bone cancer	0.000357	0.0131	CbGpPWpGaD
Cilostazol—Agranulocytosis—Epirubicin—bone cancer	0.000356	0.00172	CcSEcCtD
Cilostazol—Pneumonia—Doxorubicin—bone cancer	0.000355	0.00172	CcSEcCtD
Cilostazol—Stevens-Johnson syndrome—Doxorubicin—bone cancer	0.00035	0.00169	CcSEcCtD
Cilostazol—Erythema multiforme—Methotrexate—bone cancer	0.000346	0.00167	CcSEcCtD
Cilostazol—CYP2C19—Metapathway biotransformation—CYP4V2—bone cancer	0.000346	0.0127	CbGpPWpGaD
Cilostazol—Haemoglobin—Epirubicin—bone cancer	0.000345	0.00166	CcSEcCtD
Cilostazol—Jaundice—Doxorubicin—bone cancer	0.000344	0.00166	CcSEcCtD
Cilostazol—CYP3A5—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000344	0.0127	CbGpPWpGaD
Cilostazol—Rhinitis—Epirubicin—bone cancer	0.000344	0.00166	CcSEcCtD
Cilostazol—Urinary tract infection—Doxorubicin—bone cancer	0.000343	0.00166	CcSEcCtD
Cilostazol—Conjunctivitis—Doxorubicin—bone cancer	0.000343	0.00166	CcSEcCtD
Cilostazol—CYP2D6—Tamoxifen metabolism—CYP3A4—bone cancer	0.000343	0.0126	CbGpPWpGaD
Cilostazol—Haemorrhage—Epirubicin—bone cancer	0.000343	0.00166	CcSEcCtD
Cilostazol—Tinnitus—Methotrexate—bone cancer	0.000342	0.00165	CcSEcCtD
Cilostazol—Hypoaesthesia—Epirubicin—bone cancer	0.000341	0.00165	CcSEcCtD
Cilostazol—Asthenia—Cisplatin—bone cancer	0.00034	0.00164	CcSEcCtD
Cilostazol—Pharyngitis—Epirubicin—bone cancer	0.00034	0.00164	CcSEcCtD
Cilostazol—Cardiac disorder—Methotrexate—bone cancer	0.00034	0.00164	CcSEcCtD
Cilostazol—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000338	0.0125	CbGpPWpGaD
Cilostazol—Oedema peripheral—Epirubicin—bone cancer	0.000338	0.00163	CcSEcCtD
Cilostazol—Haematuria—Doxorubicin—bone cancer	0.000337	0.00163	CcSEcCtD
Cilostazol—Hepatobiliary disease—Doxorubicin—bone cancer	0.000334	0.00161	CcSEcCtD
Cilostazol—Epistaxis—Doxorubicin—bone cancer	0.000333	0.00161	CcSEcCtD
Cilostazol—Angiopathy—Methotrexate—bone cancer	0.000332	0.0016	CcSEcCtD
Cilostazol—Sinusitis—Doxorubicin—bone cancer	0.000332	0.0016	CcSEcCtD
Cilostazol—Mediastinal disorder—Methotrexate—bone cancer	0.00033	0.00159	CcSEcCtD
Cilostazol—Agranulocytosis—Doxorubicin—bone cancer	0.00033	0.00159	CcSEcCtD
Cilostazol—Chills—Methotrexate—bone cancer	0.000329	0.00159	CcSEcCtD
Cilostazol—CYP1A2—Estrogen metabolism—CYP3A4—bone cancer	0.000329	0.0121	CbGpPWpGaD
Cilostazol—Diarrhoea—Cisplatin—bone cancer	0.000325	0.00157	CcSEcCtD
Cilostazol—Erythema multiforme—Epirubicin—bone cancer	0.000324	0.00156	CcSEcCtD
Cilostazol—Tinnitus—Epirubicin—bone cancer	0.00032	0.00154	CcSEcCtD
Cilostazol—Haemoglobin—Doxorubicin—bone cancer	0.000319	0.00154	CcSEcCtD
Cilostazol—Cardiac disorder—Epirubicin—bone cancer	0.000318	0.00154	CcSEcCtD
Cilostazol—Rhinitis—Doxorubicin—bone cancer	0.000318	0.00154	CcSEcCtD
Cilostazol—CYP2D6—Metapathway biotransformation—CYP4V2—bone cancer	0.000318	0.0117	CbGpPWpGaD
Cilostazol—Haemorrhage—Doxorubicin—bone cancer	0.000317	0.00153	CcSEcCtD
Cilostazol—Hypoaesthesia—Doxorubicin—bone cancer	0.000316	0.00152	CcSEcCtD
Cilostazol—Pharyngitis—Doxorubicin—bone cancer	0.000315	0.00152	CcSEcCtD
Cilostazol—CYP1A2—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.000315	0.0116	CbGpPWpGaD
Cilostazol—Oedema peripheral—Doxorubicin—bone cancer	0.000312	0.00151	CcSEcCtD
Cilostazol—Angiopathy—Epirubicin—bone cancer	0.000311	0.0015	CcSEcCtD
Cilostazol—Mediastinal disorder—Epirubicin—bone cancer	0.000309	0.00149	CcSEcCtD
Cilostazol—Back pain—Methotrexate—bone cancer	0.000308	0.00149	CcSEcCtD
Cilostazol—Chills—Epirubicin—bone cancer	0.000308	0.00149	CcSEcCtD
Cilostazol—CYP1A2—Xenobiotics—CYP3A4—bone cancer	0.000302	0.0111	CbGpPWpGaD
Cilostazol—Vomiting—Cisplatin—bone cancer	0.000302	0.00146	CcSEcCtD
Cilostazol—Erythema multiforme—Doxorubicin—bone cancer	0.0003	0.00145	CcSEcCtD
Cilostazol—Rash—Cisplatin—bone cancer	0.000299	0.00144	CcSEcCtD
Cilostazol—Dermatitis—Cisplatin—bone cancer	0.000299	0.00144	CcSEcCtD
Cilostazol—Ill-defined disorder—Methotrexate—bone cancer	0.000296	0.00143	CcSEcCtD
Cilostazol—Tinnitus—Doxorubicin—bone cancer	0.000296	0.00143	CcSEcCtD
Cilostazol—Anaemia—Methotrexate—bone cancer	0.000295	0.00142	CcSEcCtD
Cilostazol—Cardiac disorder—Doxorubicin—bone cancer	0.000294	0.00142	CcSEcCtD
Cilostazol—Flatulence—Epirubicin—bone cancer	0.000294	0.00142	CcSEcCtD
Cilostazol—CYP1A2—Tamoxifen metabolism—CYP3A4—bone cancer	0.00029	0.0107	CbGpPWpGaD
Cilostazol—Back pain—Epirubicin—bone cancer	0.000289	0.00139	CcSEcCtD
Cilostazol—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000288	0.0106	CbGpPWpGaD
Cilostazol—Angiopathy—Doxorubicin—bone cancer	0.000288	0.00139	CcSEcCtD
Cilostazol—Malaise—Methotrexate—bone cancer	0.000288	0.00139	CcSEcCtD
Cilostazol—Muscle spasms—Epirubicin—bone cancer	0.000287	0.00139	CcSEcCtD
Cilostazol—Vertigo—Methotrexate—bone cancer	0.000287	0.00138	CcSEcCtD
Cilostazol—Mediastinal disorder—Doxorubicin—bone cancer	0.000286	0.00138	CcSEcCtD
Cilostazol—Leukopenia—Methotrexate—bone cancer	0.000285	0.00138	CcSEcCtD
Cilostazol—Chills—Doxorubicin—bone cancer	0.000285	0.00137	CcSEcCtD
Cilostazol—CYP3A7—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000284	0.0105	CbGpPWpGaD
Cilostazol—Nausea—Cisplatin—bone cancer	0.000282	0.00136	CcSEcCtD
Cilostazol—Cough—Methotrexate—bone cancer	0.000278	0.00134	CcSEcCtD
Cilostazol—Ill-defined disorder—Epirubicin—bone cancer	0.000277	0.00134	CcSEcCtD
Cilostazol—Anaemia—Epirubicin—bone cancer	0.000276	0.00133	CcSEcCtD
Cilostazol—Flatulence—Doxorubicin—bone cancer	0.000272	0.00131	CcSEcCtD
Cilostazol—Arthralgia—Methotrexate—bone cancer	0.000272	0.00131	CcSEcCtD
Cilostazol—Myalgia—Methotrexate—bone cancer	0.000272	0.00131	CcSEcCtD
Cilostazol—Chest pain—Methotrexate—bone cancer	0.000272	0.00131	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.00027	0.0013	CcSEcCtD
Cilostazol—CYP1A2—Metapathway biotransformation—CYP4V2—bone cancer	0.000269	0.00993	CbGpPWpGaD
Cilostazol—Malaise—Epirubicin—bone cancer	0.000269	0.0013	CcSEcCtD
Cilostazol—Discomfort—Methotrexate—bone cancer	0.000268	0.0013	CcSEcCtD
Cilostazol—Vertigo—Epirubicin—bone cancer	0.000268	0.00129	CcSEcCtD
Cilostazol—Syncope—Epirubicin—bone cancer	0.000268	0.00129	CcSEcCtD
Cilostazol—Leukopenia—Epirubicin—bone cancer	0.000267	0.00129	CcSEcCtD
Cilostazol—Back pain—Doxorubicin—bone cancer	0.000267	0.00129	CcSEcCtD
Cilostazol—CYP2C19—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000266	0.00981	CbGpPWpGaD
Cilostazol—Muscle spasms—Doxorubicin—bone cancer	0.000265	0.00128	CcSEcCtD
Cilostazol—Palpitations—Epirubicin—bone cancer	0.000264	0.00127	CcSEcCtD
Cilostazol—Loss of consciousness—Epirubicin—bone cancer	0.000262	0.00127	CcSEcCtD
Cilostazol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000261	0.00962	CbGpPWpGaD
Cilostazol—Cough—Epirubicin—bone cancer	0.00026	0.00126	CcSEcCtD
Cilostazol—Infection—Methotrexate—bone cancer	0.000259	0.00125	CcSEcCtD
Cilostazol—Hypertension—Epirubicin—bone cancer	0.000258	0.00124	CcSEcCtD
Cilostazol—Ill-defined disorder—Doxorubicin—bone cancer	0.000256	0.00124	CcSEcCtD
Cilostazol—Nervous system disorder—Methotrexate—bone cancer	0.000255	0.00123	CcSEcCtD
Cilostazol—Anaemia—Doxorubicin—bone cancer	0.000255	0.00123	CcSEcCtD
Cilostazol—Thrombocytopenia—Methotrexate—bone cancer	0.000255	0.00123	CcSEcCtD
Cilostazol—Chest pain—Epirubicin—bone cancer	0.000254	0.00123	CcSEcCtD
Cilostazol—Arthralgia—Epirubicin—bone cancer	0.000254	0.00123	CcSEcCtD
Cilostazol—Myalgia—Epirubicin—bone cancer	0.000254	0.00123	CcSEcCtD
Cilostazol—Anxiety—Epirubicin—bone cancer	0.000253	0.00122	CcSEcCtD
Cilostazol—Skin disorder—Methotrexate—bone cancer	0.000253	0.00122	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000252	0.00122	CcSEcCtD
Cilostazol—Discomfort—Epirubicin—bone cancer	0.000251	0.00121	CcSEcCtD
Cilostazol—Malaise—Doxorubicin—bone cancer	0.000249	0.0012	CcSEcCtD
Cilostazol—Vertigo—Doxorubicin—bone cancer	0.000248	0.0012	CcSEcCtD
Cilostazol—Anorexia—Methotrexate—bone cancer	0.000248	0.0012	CcSEcCtD
Cilostazol—Syncope—Doxorubicin—bone cancer	0.000248	0.0012	CcSEcCtD
Cilostazol—Leukopenia—Doxorubicin—bone cancer	0.000247	0.00119	CcSEcCtD
Cilostazol—Palpitations—Doxorubicin—bone cancer	0.000244	0.00118	CcSEcCtD
Cilostazol—Oedema—Epirubicin—bone cancer	0.000244	0.00118	CcSEcCtD
Cilostazol—Hypotension—Methotrexate—bone cancer	0.000243	0.00117	CcSEcCtD
Cilostazol—Loss of consciousness—Doxorubicin—bone cancer	0.000243	0.00117	CcSEcCtD
Cilostazol—Infection—Epirubicin—bone cancer	0.000242	0.00117	CcSEcCtD
Cilostazol—Cough—Doxorubicin—bone cancer	0.000241	0.00116	CcSEcCtD
Cilostazol—Shock—Epirubicin—bone cancer	0.00024	0.00116	CcSEcCtD
Cilostazol—Nervous system disorder—Epirubicin—bone cancer	0.000239	0.00115	CcSEcCtD
Cilostazol—Thrombocytopenia—Epirubicin—bone cancer	0.000238	0.00115	CcSEcCtD
Cilostazol—Hypertension—Doxorubicin—bone cancer	0.000238	0.00115	CcSEcCtD
Cilostazol—Tachycardia—Epirubicin—bone cancer	0.000238	0.00115	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000237	0.00114	CcSEcCtD
Cilostazol—Skin disorder—Epirubicin—bone cancer	0.000237	0.00114	CcSEcCtD
Cilostazol—Insomnia—Methotrexate—bone cancer	0.000235	0.00114	CcSEcCtD
Cilostazol—Chest pain—Doxorubicin—bone cancer	0.000235	0.00113	CcSEcCtD
Cilostazol—Arthralgia—Doxorubicin—bone cancer	0.000235	0.00113	CcSEcCtD
Cilostazol—Myalgia—Doxorubicin—bone cancer	0.000235	0.00113	CcSEcCtD
Cilostazol—Anxiety—Doxorubicin—bone cancer	0.000234	0.00113	CcSEcCtD
Cilostazol—Paraesthesia—Methotrexate—bone cancer	0.000234	0.00113	CcSEcCtD
Cilostazol—CYP3A7—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000233	0.00861	CbGpPWpGaD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000233	0.00113	CcSEcCtD
Cilostazol—Discomfort—Doxorubicin—bone cancer	0.000232	0.00112	CcSEcCtD
Cilostazol—Anorexia—Epirubicin—bone cancer	0.000232	0.00112	CcSEcCtD
Cilostazol—Dyspnoea—Methotrexate—bone cancer	0.000232	0.00112	CcSEcCtD
Cilostazol—Dyspepsia—Methotrexate—bone cancer	0.000229	0.00111	CcSEcCtD
Cilostazol—Hypotension—Epirubicin—bone cancer	0.000228	0.0011	CcSEcCtD
Cilostazol—Decreased appetite—Methotrexate—bone cancer	0.000226	0.00109	CcSEcCtD
Cilostazol—Oedema—Doxorubicin—bone cancer	0.000225	0.00109	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Methotrexate—bone cancer	0.000225	0.00108	CcSEcCtD
Cilostazol—Infection—Doxorubicin—bone cancer	0.000224	0.00108	CcSEcCtD
Cilostazol—Pain—Methotrexate—bone cancer	0.000223	0.00107	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Epirubicin—bone cancer	0.000222	0.00107	CcSEcCtD
Cilostazol—Shock—Doxorubicin—bone cancer	0.000222	0.00107	CcSEcCtD
Cilostazol—Nervous system disorder—Doxorubicin—bone cancer	0.000221	0.00107	CcSEcCtD
Cilostazol—Thrombocytopenia—Doxorubicin—bone cancer	0.000221	0.00107	CcSEcCtD
Cilostazol—Insomnia—Epirubicin—bone cancer	0.00022	0.00106	CcSEcCtD
Cilostazol—Tachycardia—Doxorubicin—bone cancer	0.00022	0.00106	CcSEcCtD
Cilostazol—Skin disorder—Doxorubicin—bone cancer	0.000219	0.00106	CcSEcCtD
Cilostazol—Paraesthesia—Epirubicin—bone cancer	0.000219	0.00106	CcSEcCtD
Cilostazol—Dyspnoea—Epirubicin—bone cancer	0.000217	0.00105	CcSEcCtD
Cilostazol—Anorexia—Doxorubicin—bone cancer	0.000215	0.00104	CcSEcCtD
Cilostazol—Feeling abnormal—Methotrexate—bone cancer	0.000214	0.00104	CcSEcCtD
Cilostazol—Dyspepsia—Epirubicin—bone cancer	0.000214	0.00104	CcSEcCtD
Cilostazol—Gastrointestinal pain—Methotrexate—bone cancer	0.000213	0.00103	CcSEcCtD
Cilostazol—Decreased appetite—Epirubicin—bone cancer	0.000212	0.00102	CcSEcCtD
Cilostazol—Hypotension—Doxorubicin—bone cancer	0.000211	0.00102	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Epirubicin—bone cancer	0.00021	0.00102	CcSEcCtD
Cilostazol—Pain—Epirubicin—bone cancer	0.000208	0.00101	CcSEcCtD
Cilostazol—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000208	0.00768	CbGpPWpGaD
Cilostazol—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.000208	0.00767	CbGpPWpGaD
Cilostazol—Urticaria—Methotrexate—bone cancer	0.000207	0.000998	CcSEcCtD
Cilostazol—Aripiprazole—CYP3A4—bone cancer	0.000206	1	CrCbGaD
Cilostazol—Abdominal pain—Methotrexate—bone cancer	0.000206	0.000993	CcSEcCtD
Cilostazol—Body temperature increased—Methotrexate—bone cancer	0.000206	0.000993	CcSEcCtD
Cilostazol—CYP3A5—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000205	0.00758	CbGpPWpGaD
Cilostazol—Musculoskeletal discomfort—Doxorubicin—bone cancer	0.000205	0.000991	CcSEcCtD
Cilostazol—Insomnia—Doxorubicin—bone cancer	0.000204	0.000984	CcSEcCtD
Cilostazol—Paraesthesia—Doxorubicin—bone cancer	0.000202	0.000977	CcSEcCtD
Cilostazol—Dyspnoea—Doxorubicin—bone cancer	0.000201	0.00097	CcSEcCtD
Cilostazol—Feeling abnormal—Epirubicin—bone cancer	0.000201	0.000969	CcSEcCtD
Cilostazol—Gastrointestinal pain—Epirubicin—bone cancer	0.000199	0.000962	CcSEcCtD
Cilostazol—Dyspepsia—Doxorubicin—bone cancer	0.000198	0.000958	CcSEcCtD
Cilostazol—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000198	0.00728	CbGpPWpGaD
Cilostazol—Decreased appetite—Doxorubicin—bone cancer	0.000196	0.000946	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Doxorubicin—bone cancer	0.000195	0.000939	CcSEcCtD
Cilostazol—Urticaria—Epirubicin—bone cancer	0.000193	0.000934	CcSEcCtD
Cilostazol—Pain—Doxorubicin—bone cancer	0.000193	0.00093	CcSEcCtD
Cilostazol—Body temperature increased—Epirubicin—bone cancer	0.000193	0.00093	CcSEcCtD
Cilostazol—Abdominal pain—Epirubicin—bone cancer	0.000193	0.00093	CcSEcCtD
Cilostazol—Asthenia—Methotrexate—bone cancer	0.000187	0.000902	CcSEcCtD
Cilostazol—Feeling abnormal—Doxorubicin—bone cancer	0.000186	0.000897	CcSEcCtD
Cilostazol—Gastrointestinal pain—Doxorubicin—bone cancer	0.000184	0.00089	CcSEcCtD
Cilostazol—Pruritus—Methotrexate—bone cancer	0.000184	0.000889	CcSEcCtD
Cilostazol—Urticaria—Doxorubicin—bone cancer	0.000179	0.000864	CcSEcCtD
Cilostazol—Abdominal pain—Doxorubicin—bone cancer	0.000178	0.00086	CcSEcCtD
Cilostazol—Body temperature increased—Doxorubicin—bone cancer	0.000178	0.00086	CcSEcCtD
Cilostazol—Diarrhoea—Methotrexate—bone cancer	0.000178	0.00086	CcSEcCtD
Cilostazol—Asthenia—Epirubicin—bone cancer	0.000175	0.000844	CcSEcCtD
Cilostazol—Pruritus—Epirubicin—bone cancer	0.000172	0.000832	CcSEcCtD
Cilostazol—Dizziness—Methotrexate—bone cancer	0.000172	0.000831	CcSEcCtD
Cilostazol—CYP1A2—Estrogen Receptor Pathway—JUN—bone cancer	0.00017	0.00628	CbGpPWpGaD
Cilostazol—CYP3A5—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000169	0.00622	CbGpPWpGaD
Cilostazol—Diarrhoea—Epirubicin—bone cancer	0.000167	0.000805	CcSEcCtD
Cilostazol—Vomiting—Methotrexate—bone cancer	0.000165	0.000799	CcSEcCtD
Cilostazol—Rash—Methotrexate—bone cancer	0.000164	0.000792	CcSEcCtD
Cilostazol—Dermatitis—Methotrexate—bone cancer	0.000164	0.000792	CcSEcCtD
Cilostazol—Headache—Methotrexate—bone cancer	0.000163	0.000787	CcSEcCtD
Cilostazol—Asthenia—Doxorubicin—bone cancer	0.000162	0.000781	CcSEcCtD
Cilostazol—Dizziness—Epirubicin—bone cancer	0.000161	0.000778	CcSEcCtD
Cilostazol—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000161	0.00594	CbGpPWpGaD
Cilostazol—Pruritus—Doxorubicin—bone cancer	0.000159	0.00077	CcSEcCtD
Cilostazol—CYP2C19—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000159	0.00586	CbGpPWpGaD
Cilostazol—CYP1A2—Tryptophan metabolism—CYP3A4—bone cancer	0.000155	0.00572	CbGpPWpGaD
Cilostazol—Vomiting—Epirubicin—bone cancer	0.000155	0.000748	CcSEcCtD
Cilostazol—Nausea—Methotrexate—bone cancer	0.000155	0.000746	CcSEcCtD
Cilostazol—Diarrhoea—Doxorubicin—bone cancer	0.000154	0.000744	CcSEcCtD
Cilostazol—Rash—Epirubicin—bone cancer	0.000154	0.000741	CcSEcCtD
Cilostazol—Dermatitis—Epirubicin—bone cancer	0.000153	0.000741	CcSEcCtD
Cilostazol—Headache—Epirubicin—bone cancer	0.000153	0.000737	CcSEcCtD
Cilostazol—Dizziness—Doxorubicin—bone cancer	0.000149	0.000719	CcSEcCtD
Cilostazol—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000148	0.00546	CbGpPWpGaD
Cilostazol—CYP2D6—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000146	0.00539	CbGpPWpGaD
Cilostazol—Nausea—Epirubicin—bone cancer	0.000145	0.000698	CcSEcCtD
Cilostazol—Vomiting—Doxorubicin—bone cancer	0.000143	0.000692	CcSEcCtD
Cilostazol—Rash—Doxorubicin—bone cancer	0.000142	0.000686	CcSEcCtD
Cilostazol—Dermatitis—Doxorubicin—bone cancer	0.000142	0.000685	CcSEcCtD
Cilostazol—Headache—Doxorubicin—bone cancer	0.000141	0.000682	CcSEcCtD
Cilostazol—PDE3A—GPCR downstream signaling—GRM4—bone cancer	0.000138	0.00508	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—RGS1—bone cancer	0.000138	0.00508	CbGpPWpGaD
Cilostazol—Nausea—Doxorubicin—bone cancer	0.000134	0.000646	CcSEcCtD
Cilostazol—PDE3A—Hemostasis—SPARC—bone cancer	0.000133	0.00491	CbGpPWpGaD
Cilostazol—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00013	0.00481	CbGpPWpGaD
Cilostazol—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000125	0.00462	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—GRM4—bone cancer	0.000125	0.00461	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—RGS1—bone cancer	0.000125	0.00461	CbGpPWpGaD
Cilostazol—CYP3A7—Biological oxidations—CYP3A4—bone cancer	0.000124	0.00457	CbGpPWpGaD
Cilostazol—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000124	0.00456	CbGpPWpGaD
Cilostazol—CYP3A7—Metapathway biotransformation—CYP3A4—bone cancer	0.000122	0.00451	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—GNA11—bone cancer	0.000122	0.00449	CbGpPWpGaD
Cilostazol—CYP2D6—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00012	0.00443	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—GRM1—bone cancer	0.000119	0.00441	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—IL3—bone cancer	0.00011	0.00407	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—GRM1—bone cancer	0.000108	0.004	CbGpPWpGaD
Cilostazol—CYP3A7—Biological oxidations—GSTP1—bone cancer	0.000106	0.00391	CbGpPWpGaD
Cilostazol—CYP3A7—Metapathway biotransformation—GSTP1—bone cancer	0.000105	0.00386	CbGpPWpGaD
Cilostazol—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000102	0.00375	CbGpPWpGaD
Cilostazol—CYP3A5—Biological oxidations—CYP3A4—bone cancer	8.96e-05	0.00331	CbGpPWpGaD
Cilostazol—CYP3A5—Metapathway biotransformation—CYP3A4—bone cancer	8.84e-05	0.00326	CbGpPWpGaD
Cilostazol—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	8.36e-05	0.00308	CbGpPWpGaD
Cilostazol—CYP2C19—Arachidonic acid metabolism—PTGS2—bone cancer	8.25e-05	0.00304	CbGpPWpGaD
Cilostazol—CYP1A2—Phase II conjugation—GSTP1—bone cancer	7.9e-05	0.00291	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—GNA11—bone cancer	7.7e-05	0.00284	CbGpPWpGaD
Cilostazol—CYP3A5—Biological oxidations—GSTP1—bone cancer	7.67e-05	0.00283	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—SMO—bone cancer	7.64e-05	0.00282	CbGpPWpGaD
Cilostazol—CYP3A5—Metapathway biotransformation—GSTP1—bone cancer	7.56e-05	0.00279	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—NDUFA12—bone cancer	7.43e-05	0.00274	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—RGS1—bone cancer	7.39e-05	0.00273	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—GRM4—bone cancer	7.39e-05	0.00273	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—PLAU—bone cancer	7.24e-05	0.00267	CbGpPWpGaD
Cilostazol—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	7.13e-05	0.00263	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—GNA11—bone cancer	6.99e-05	0.00258	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—IL3—bone cancer	6.98e-05	0.00257	CbGpPWpGaD
Cilostazol—CYP2C19—Biological oxidations—CYP3A4—bone cancer	6.93e-05	0.00256	CbGpPWpGaD
Cilostazol—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	6.87e-05	0.00253	CbGpPWpGaD
Cilostazol—CYP2C19—Metapathway biotransformation—CYP3A4—bone cancer	6.84e-05	0.00252	CbGpPWpGaD
Cilostazol—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	6.43e-05	0.00237	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—GRM1—bone cancer	6.41e-05	0.00236	CbGpPWpGaD
Cilostazol—CYP2D6—Biological oxidations—CYP3A4—bone cancer	6.37e-05	0.00235	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—IL3—bone cancer	6.34e-05	0.00234	CbGpPWpGaD
Cilostazol—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	6.29e-05	0.00232	CbGpPWpGaD
Cilostazol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	6.2e-05	0.00229	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—NT5C3A—bone cancer	6.16e-05	0.00227	CbGpPWpGaD
Cilostazol—CYP2C19—Biological oxidations—GSTP1—bone cancer	5.93e-05	0.00219	CbGpPWpGaD
Cilostazol—CYP2C19—Metapathway biotransformation—GSTP1—bone cancer	5.85e-05	0.00216	CbGpPWpGaD
Cilostazol—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	5.5e-05	0.00203	CbGpPWpGaD
Cilostazol—CYP2D6—Biological oxidations—GSTP1—bone cancer	5.45e-05	0.00201	CbGpPWpGaD
Cilostazol—CYP1A2—Biological oxidations—CYP3A4—bone cancer	5.4e-05	0.00199	CbGpPWpGaD
Cilostazol—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	5.38e-05	0.00198	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—NDUFA12—bone cancer	5.37e-05	0.00198	CbGpPWpGaD
Cilostazol—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	5.33e-05	0.00196	CbGpPWpGaD
Cilostazol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	4.87e-05	0.0018	CbGpPWpGaD
Cilostazol—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	4.87e-05	0.0018	CbGpPWpGaD
Cilostazol—CYP1A2—Biological oxidations—GSTP1—bone cancer	4.62e-05	0.0017	CbGpPWpGaD
Cilostazol—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	4.56e-05	0.00168	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—SMO—bone cancer	4.52e-05	0.00167	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—NT5C3A—bone cancer	4.45e-05	0.00164	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—NDUFA12—bone cancer	4.15e-05	0.00153	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—GNA11—bone cancer	4.13e-05	0.00152	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—ATF1—bone cancer	3.84e-05	0.00142	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—NDUFA12—bone cancer	3.82e-05	0.00141	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—IL3—bone cancer	3.74e-05	0.00138	CbGpPWpGaD
Cilostazol—CYP3A4—Biological oxidations—GSTP1—bone cancer	3.56e-05	0.00131	CbGpPWpGaD
Cilostazol—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	3.52e-05	0.0013	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—NT5C3A—bone cancer	3.44e-05	0.00127	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—NDUFA12—bone cancer	3.24e-05	0.00119	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—TGFBR2—bone cancer	3.2e-05	0.00118	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—NT5C3A—bone cancer	3.17e-05	0.00117	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—IGF1R—bone cancer	3.01e-05	0.00111	CbGpPWpGaD
Cilostazol—PDE3A—Hemostasis—TP53—bone cancer	2.91e-05	0.00107	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—ENO2—bone cancer	2.7e-05	0.000995	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—NT5C3A—bone cancer	2.68e-05	0.000989	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—DHFR—bone cancer	2.5e-05	0.000923	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—NDUFA12—bone cancer	2.5e-05	0.000921	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—GNA11—bone cancer	2.34e-05	0.000863	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—KIT—bone cancer	2.18e-05	0.000806	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—CYP3A4—bone cancer	2.12e-05	0.000782	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—NT5C3A—bone cancer	2.07e-05	0.000763	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—BRAF—bone cancer	2.05e-05	0.000757	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—EGFR—bone cancer	1.99e-05	0.000734	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ENO2—bone cancer	1.95e-05	0.000719	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—GSTP1—bone cancer	1.81e-05	0.000669	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—DHFR—bone cancer	1.81e-05	0.000667	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—MDM2—bone cancer	1.72e-05	0.000635	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GNA11—bone cancer	1.69e-05	0.000624	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CYP3A4—bone cancer	1.53e-05	0.000565	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ENO2—bone cancer	1.51e-05	0.000556	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—JUN—bone cancer	1.5e-05	0.000552	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—MMP9—bone cancer	1.46e-05	0.000537	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—DHFR—bone cancer	1.4e-05	0.000516	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ENO2—bone cancer	1.39e-05	0.000511	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GSTP1—bone cancer	1.31e-05	0.000484	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GNA11—bone cancer	1.31e-05	0.000482	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—DHFR—bone cancer	1.29e-05	0.000474	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GNA11—bone cancer	1.2e-05	0.000443	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CYP3A4—bone cancer	1.19e-05	0.000437	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.18e-05	0.000435	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—EGFR—bone cancer	1.18e-05	0.000434	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ENO2—bone cancer	1.17e-05	0.000433	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CYP3A4—bone cancer	1.09e-05	0.000402	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—DHFR—bone cancer	1.09e-05	0.000402	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GNA11—bone cancer	1.02e-05	0.000376	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GSTP1—bone cancer	1.01e-05	0.000374	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—TP53—bone cancer	9.87e-06	0.000364	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PTGS2—bone cancer	9.4e-06	0.000347	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GSTP1—bone cancer	9.32e-06	0.000344	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CYP3A4—bone cancer	9.24e-06	0.000341	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	9.19e-06	0.000339	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ENO2—bone cancer	9.07e-06	0.000334	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—DHFR—bone cancer	8.41e-06	0.00031	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GSTP1—bone cancer	7.9e-06	0.000291	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GNA11—bone cancer	7.86e-06	0.00029	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PTGS2—bone cancer	6.79e-06	0.000251	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTP1—bone cancer	6.1e-06	0.000225	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PTGS2—bone cancer	5.25e-06	0.000194	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PTGS2—bone cancer	4.83e-06	0.000178	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PTGS2—bone cancer	4.09e-06	0.000151	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PTGS2—bone cancer	3.16e-06	0.000116	CbGpPWpGaD
